longevitywatch
Research · Heart & vessels

Women’s heart care fails across all four life stages

LongevityWatch editors · October 27, 2026 · 2 min

Cardiovascular disease is the leading cause of death in women. Yet medical care for it is poorly tailored to female biology. A new framework from four American medical societies spells out how heart care falls short at every stage of a woman’s life. The researchers published their recommendations in the journal Circulation.

Women’s hearts differ from men’s. Heart muscle cells carry a different chromosomal makeup. Heart attack symptoms differ. The causes of heart disease overlap, but are not identical. Yet clinical guidelines and treatment protocols were built for decades primarily on male participants. Women were only required to be included in US clinical trials from 1993 onwards. That knowledge gap has medical consequences that follow women throughout their lives.

Four life stages, four blind spots

The new framework addresses heart care at four stages: girls and adolescents, women of reproductive age, pregnancy and the postpartum period, and later life. Each stage carries specific risk factors and gaps in care. Pregnancy, for example, temporarily increases the load on the heart. Complications during pregnancy can be an early signal of cardiovascular disease later in life. That connection is rarely made in clinical practice.

The four organisations that developed the framework are the American Heart Association, the American Academy of Pediatrics, the Society for Maternal-Fetal Medicine, and the American College of Obstetricians and Gynecologists. The collaboration across four specialties is itself significant. Women’s heart problems have long fallen between the disciplines of cardiology, gynaecology, and internal medicine.

A longevity perspective: heart health and lifespan

Cardiovascular disease is not only the leading killer of women. It is also a major driver of functional decline in later life. Women who survive heart disease more often live with lasting limitations than men do. Earlier intervention, better matched to female biology, could change that. For now, that remains a promise rather than a proven outcome. But this framework is a step toward the research that could deliver it.

The content of the three individual articles published in Circulation falls outside this summary. Further details are available in the original publications.

Read the original article

Search terms to explore further: cardiovascular risk women life stages, pregnancy complications heart disease, sex differences cardiology

What does the evidence say?
What does menopause do to your risk of cardiovascular disease?
Related research
24 Oct
A human blood vessel atlas maps how arteries age
20 Oct
Protein MTR4 slows cell ageing in blood vessel walls in mice
17 Oct
Every aging mechanism also damages blood vessels
Newsletter

Stay in the loop

Every Thursday, the most important longevity research in your inbox, focused on what you follow.